Literature DB >> 31975837

Cognitive Functioning in Older Adults With Schizophrenia.

Tessa Murante1, Carl I Cohen1.   

Abstract

Cognitive deficits are thought to be a core feature in schizophrenia and have been found to be strongly associated with impairments in functioning. It is estimated that more than 70% of patients with schizophrenia have cognitive impairment. The aim of this article is to critically review the emerging literature on cognition in older adults with schizophrenia. Specifically, we address the following questions: Are there differences in cognitive functioning between older adults with schizophrenia and their healthy age peers as well as with younger people with schizophrenia? What are the factors associated with cognitive deficits and their interaction over time? What are the life course trajectories of cognitive deficits, especially in later life? Are older adults with schizophrenia more likely to develop dementia, and, if so, does it differ from other dementias? Are there pharmacological and psychosocial interventions that can successfully treat cognitive deficits in older adults with schizophrenia?
Copyright © 2017 by the American Psychiatric Association.

Entities:  

Keywords:  Aging; Cognition; Neurocognition; Older Adults; Schizophrenia

Year:  2017        PMID: 31975837      PMCID: PMC6519630          DOI: 10.1176/appi.focus.20160032

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN: 1541-4094


  2 in total

Review 1.  Association of lncRNA with regulatory molecular factors in brain and their role in the pathophysiology of schizophrenia.

Authors:  Parinita Mishra; Santosh Kumar
Journal:  Metab Brain Dis       Date:  2021-02-20       Impact factor: 3.584

2.  The prevalence of depressive and anxiety symptoms and their associations with quality of life among clinically stable older patients with psychiatric disorders during the COVID-19 pandemic.

Authors:  Wen Li; Na Zhao; Xiaona Yan; Siyun Zou; Huan Wang; Yulong Li; Xiuying Xu; Xiangdong Du; Lan Zhang; Qinge Zhang; Teris Cheung; Gabor S Ungvari; Chee H Ng; Yu-Tao Xiang
Journal:  Transl Psychiatry       Date:  2021-01-26       Impact factor: 6.222

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.